Cargando…
Examining the paradoxical effects of kratom: a narrative inquiry
Introduction: Surveys and case reports have documented kratom use in the United States (US) for over a decade. However, those reports have generally not examined in depth the role kratom plays in the lives of those who use it regularly for sustained periods. Until there are controlled studies of the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196254/ https://www.ncbi.nlm.nih.gov/pubmed/37214465 http://dx.doi.org/10.3389/fphar.2023.1174139 |
_version_ | 1785044307647922176 |
---|---|
author | Smith, Kirsten E. Feldman, Jeffrey D. Dunn, Kelly E. McCurdy, Christopher R. Weiss, Stephanie T. Grundmann, Oliver Garcia-Romeu, Albert Nichels, Janeen Epstein, David H. |
author_facet | Smith, Kirsten E. Feldman, Jeffrey D. Dunn, Kelly E. McCurdy, Christopher R. Weiss, Stephanie T. Grundmann, Oliver Garcia-Romeu, Albert Nichels, Janeen Epstein, David H. |
author_sort | Smith, Kirsten E. |
collection | PubMed |
description | Introduction: Surveys and case reports have documented kratom use in the United States (US) for over a decade. However, those reports have generally not examined in depth the role kratom plays in the lives of those who use it regularly for sustained periods. Until there are controlled studies of the pharmacology and subjective effects of kratom alkaloids in humans, one of the best sources of insight on kratom-product use remains qualitative data with nuanced descriptions of kratom effects from those who use it regularly. Method: We conducted semistructured qualitative interviews with adults who regularly use kratom products, as part of a laboratory study of kratom-product self-administration. This qualitative component of the study was conducted as a narrative case-report series (n = 10). Results: Despite some differences among participants, all experienced acute combination effects that were largely, even simultaneously, analgesic and stimulatory. Most participants had decreased their dosages over time, and one planned to quit. Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). When kratom was inadvertently taken in larger than intended doses, participants described a constellation of symptoms that they called “the wobbles” (a jittery feeling accompanied by what seemed to be nystagmus); this was rare, but could be of scientific and clinical interest as a possible manifestation of serotonin syndrome. Most participants described tolerance but considered kratom generally safe at low-moderate doses, providing perceived benefits with less potential risk for adverse effects compared to pharmaceuticals or illicit drugs. Discussion: In-depth interview data like these help confirm and clarify findings from larger survey studies and clinician-driven case reports. They are needed to inform the policy practice regarding kratom and may also help inform future experimental designs. |
format | Online Article Text |
id | pubmed-10196254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101962542023-05-20 Examining the paradoxical effects of kratom: a narrative inquiry Smith, Kirsten E. Feldman, Jeffrey D. Dunn, Kelly E. McCurdy, Christopher R. Weiss, Stephanie T. Grundmann, Oliver Garcia-Romeu, Albert Nichels, Janeen Epstein, David H. Front Pharmacol Pharmacology Introduction: Surveys and case reports have documented kratom use in the United States (US) for over a decade. However, those reports have generally not examined in depth the role kratom plays in the lives of those who use it regularly for sustained periods. Until there are controlled studies of the pharmacology and subjective effects of kratom alkaloids in humans, one of the best sources of insight on kratom-product use remains qualitative data with nuanced descriptions of kratom effects from those who use it regularly. Method: We conducted semistructured qualitative interviews with adults who regularly use kratom products, as part of a laboratory study of kratom-product self-administration. This qualitative component of the study was conducted as a narrative case-report series (n = 10). Results: Despite some differences among participants, all experienced acute combination effects that were largely, even simultaneously, analgesic and stimulatory. Most participants had decreased their dosages over time, and one planned to quit. Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). When kratom was inadvertently taken in larger than intended doses, participants described a constellation of symptoms that they called “the wobbles” (a jittery feeling accompanied by what seemed to be nystagmus); this was rare, but could be of scientific and clinical interest as a possible manifestation of serotonin syndrome. Most participants described tolerance but considered kratom generally safe at low-moderate doses, providing perceived benefits with less potential risk for adverse effects compared to pharmaceuticals or illicit drugs. Discussion: In-depth interview data like these help confirm and clarify findings from larger survey studies and clinician-driven case reports. They are needed to inform the policy practice regarding kratom and may also help inform future experimental designs. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196254/ /pubmed/37214465 http://dx.doi.org/10.3389/fphar.2023.1174139 Text en Copyright © 2023 Smith, Feldman, Dunn, McCurdy, Weiss, Grundmann, Garcia-Romeu, Nichels and Epstein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Smith, Kirsten E. Feldman, Jeffrey D. Dunn, Kelly E. McCurdy, Christopher R. Weiss, Stephanie T. Grundmann, Oliver Garcia-Romeu, Albert Nichels, Janeen Epstein, David H. Examining the paradoxical effects of kratom: a narrative inquiry |
title | Examining the paradoxical effects of kratom: a narrative inquiry |
title_full | Examining the paradoxical effects of kratom: a narrative inquiry |
title_fullStr | Examining the paradoxical effects of kratom: a narrative inquiry |
title_full_unstemmed | Examining the paradoxical effects of kratom: a narrative inquiry |
title_short | Examining the paradoxical effects of kratom: a narrative inquiry |
title_sort | examining the paradoxical effects of kratom: a narrative inquiry |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196254/ https://www.ncbi.nlm.nih.gov/pubmed/37214465 http://dx.doi.org/10.3389/fphar.2023.1174139 |
work_keys_str_mv | AT smithkirstene examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT feldmanjeffreyd examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT dunnkellye examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT mccurdychristopherr examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT weissstephaniet examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT grundmannoliver examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT garciaromeualbert examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT nichelsjaneen examiningtheparadoxicaleffectsofkratomanarrativeinquiry AT epsteindavidh examiningtheparadoxicaleffectsofkratomanarrativeinquiry |